Rezolute Inc (RZLT)
Healthcare
Biotechnology
4.70 $
-3.3%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Rezolute Inc (RZLT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 68.6% of the shares are freely tradable; institutional investors hold 90.4%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
90.4%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
10.2%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
68.6%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
21.6%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
96Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Federated Hermes Inc | 13.49 | 12,990,659 | -21.4 | 03/31/2026 |
| RA Capital Management, LLC | 9.53 | 9,180,000 | +0.0 | 03/31/2026 |
| BlackRock Inc | 6.56 | 6,313,503 | -6.7 | 03/31/2026 |
| Opaleye Management Inc | 6.54 | 6,300,000 | +0.2 | 03/31/2026 |
| Balyasny Asset Management LLC | 5.24 | 5,048,421 | +12.0 | 03/31/2026 |
| Vanguard Group Inc | 4.97 | 4,788,511 | +8.6 | 12/31/2025 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Federated Hermes Kaufmann R | 8.82 | 8,494,000 | +0.0 | 03/31/2026 |
| Federated Hermes Kaufmann Growth | 7.77 | 7,484,000 | +0.0 | 03/31/2026 |
| Federated Hermes Kaufmann Small Cap A | 6.42 | 6,180,760 | +0.0 | 03/31/2026 |
| Federated Hermes Kaufmann Small Cap Grow | 5.55 | 5,340,860 | +12.3 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.